Department of Hepatology, Buddhist Tzu Chi General Hospital, Taipei Branch and School of Medicine, Tzu Chi University, Hualien, Taiwan.
Kaohsiung J Med Sci. 2012 Mar;28(3):151-60. doi: 10.1016/j.kjms.2011.10.005. Epub 2012 Jan 17.
Non-alcoholic fatty liver disease is associated with an increased risk of metabolic and cardiovascular diseases. Whether the severity of fatty liver on ultrasound correlates with metabolic or cardiovascular risk remains unclear. A total of 1000 people receiving health examinations were enrolled, and 126 were excluded due to the presence of HBsAg, anti-HCV, known hepatic disorders or alcohol use (>140 g/wk). Significant fatty liver consisted of moderate and severe fatty liver on ultrasound. The definition of central obesity was modified to a waist circumference of >90 cm in men and >80 cm in women. Framingham risk score was used to estimate the risk of cardiovascular disease. A total of 874 subjects (485 women and 388 men with a mean age of 52.07 ± 11.68 years) were included in the final analysis. By using logistic regression analyses stratified by gender, the odds ratio for the prevalence of diabetes mellitus, metabolic syndrome and risk of cardiovascular disease increased with increasing fatty liver status in both genders (p ≤ 0.001). The difference was not only present between individuals with fatty liver vs. non-fatty liver but also between the mild fatty liver and significant fatty liver groups (p < 0.05). In conclusion, the severity of fatty liver on ultrasound could be useful for the risk stratification of metabolic syndrome, diabetes mellitus and cardiovascular disease in clinical practice.
非酒精性脂肪性肝病与代谢性和心血管疾病的风险增加相关。超声检查中脂肪肝的严重程度与代谢或心血管风险是否相关尚不清楚。共纳入 1000 名接受健康检查的人,由于 HBsAg、抗 HCV、已知肝疾病或酒精使用(>140 g/周)存在,126 人被排除在外。显著的脂肪肝包括超声检查中中度和重度脂肪肝。中心性肥胖的定义被修改为男性腰围>90 cm,女性腰围>80 cm。Framingham 风险评分用于估计心血管疾病的风险。共纳入 874 名受试者(485 名女性和 388 名男性,平均年龄 52.07±11.68 岁)进行最终分析。通过按性别分层的 logistic 回归分析,糖尿病、代谢综合征和心血管疾病风险的患病率比值随着两性中脂肪肝状态的增加而增加(p≤0.001)。这种差异不仅存在于有脂肪肝与无脂肪肝的个体之间,而且存在于轻度脂肪肝和显著脂肪肝组之间(p<0.05)。总之,超声检查中脂肪肝的严重程度可用于临床实践中代谢综合征、糖尿病和心血管疾病的风险分层。